Ernexa Therapeutics Inc. Capitalized Computer Software, Impairments (Deprecated 2016-01-31)
Ernexa Therapeutics Inc. (ERNA) reported Capitalized Computer Software, Impairments (Deprecated 2016-01-31) of $0 for the 3-month period ending 2014-09-30, per its 10-Q filed 2014-11-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:CapitalizedComputerSoftwareImpairments · last filed 2014-11-07
- Ernexa Therapeutics Inc. capitalized computer software, impairments (deprecated 2016-01-31) for the quarter ending 2014-09-30 was $0.00.
- Ernexa Therapeutics Inc. capitalized computer software, impairments (deprecated 2016-01-31) for the quarter ending 2014-06-30 was -$639.00K.
- Ernexa Therapeutics Inc. capitalized computer software, impairments (deprecated 2016-01-31) for the quarter ending 2014-03-31 was $22.00K, a 66.15% decline year-over-year.
- Ernexa Therapeutics Inc. capitalized computer software, impairments (deprecated 2016-01-31) for the quarter ending 2013-12-31 was $345.00K.
- Ernexa Therapeutics Inc. capitalized computer software, impairments (deprecated 2016-01-31) for fiscal 2013 was $230.00K, a 3185.71% increase from fiscal 2012.
- Ernexa Therapeutics Inc. capitalized computer software, impairments (deprecated 2016-01-31) for fiscal 2012 was $7.00K.
| Period end | Capitalized Computer Software, Impairments (Deprecated 2016-01-31) 3 month | Capitalized Computer Software, Impairments (Deprecated 2016-01-31) 3 month as first filed | Capitalized Computer Software, Impairments (Deprecated 2016-01-31) 6 month | Capitalized Computer Software, Impairments (Deprecated 2016-01-31) 6 month as first filed | Capitalized Computer Software, Impairments (Deprecated 2016-01-31) 9 month | Capitalized Computer Software, Impairments (Deprecated 2016-01-31) 9 month as first filed | Capitalized Computer Software, Impairments (Deprecated 2016-01-31) 12 month |
|---|---|---|---|---|---|---|---|
| 2014-09-30 | $0.00 10-Q · filed 2014-11-07 | -$639.00K derived: sum of 2 quarters · filed 2014-11-07 | -$661.00K 10-Q · filed 2014-11-07 | -$272.00K derived: sum of 4 quarters · filed 2014-11-07 | |||
| 2014-06-30 | -$639.00K 10-Q · filed 2014-08-14 | -$661.00K 10-Q · filed 2014-08-14 | -$272.00K derived: sum of 3 quarters · filed 2014-08-14 | -$295.00K derived: sum of 4 quarters · filed 2014-11-07 | |||
| 2014-03-31 | $22.00K 10-Q · filed 2014-05-15 | $367.00K derived: sum of 2 quarters · filed 2014-05-15 | $344.00K derived: sum of 3 quarters · filed 2014-11-07 | $317.00K derived: sum of 4 quarters · filed 2014-11-07 | |||
| 2013-12-31 | $345.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $322.00K derived: sum of 2 quarters · filed 2014-11-07 | $295.00K derived: sum of 3 quarters · filed 2014-11-07 | $230.00K 10-K · filed 2014-03-31 | |||
| 2013-09-30 | -$23.00K 10-Q · filed 2014-11-07 | $23.00K 10-Q · filed 2013-11-14 | -$50.00K derived: sum of 2 quarters · filed 2014-11-07 | -$115.00K 10-Q · filed 2014-11-07 | $115.00K 10-Q · filed 2013-11-14 | ||
| 2013-06-30 | -$27.00K 10-Q · filed 2014-08-14 | $27.00K 10-Q · filed 2013-08-14 | -$92.00K 10-Q · filed 2014-08-14 | $92.00K 10-Q · filed 2013-08-14 | |||
| 2013-03-31 | $65.00K 10-Q · filed 2014-05-15 | ||||||
| 2012-12-31 | $7.00K 10-K · filed 2014-03-31 | ||||||
| 2011-09-30 | $18.00K 10-Q · filed 2012-11-09 | $155.00K 10-Q · filed 2012-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |